Abstract:D‐3‐phosphoglycerate dehydrogenase (PHGDH) catalyzes the NAD+‐dependent conversion of D‐3‐phospho‐glycerate to 3‐phosphohydroxypyruvate, the first step in the phosphorylated pathway for L‐serine (L‐Ser) biosynthesis. L‐Ser plays different relevant metabolic roles in eukaryotic cells: alterations in L‐Ser metabolism have been linked to serious neurological disorders. The human PHGDH (hPHGDH), showing a homotetrameric state in solution, is made of four domains, among which there are two regulatory domains at the C‐terminus: the aspartate kinase‐chorismate mutase‐tyrA prephenate dehydrogenase (ACT) and allosteric substrate‐binding (ASB) domains. The structure of hPHGDH was solved only for a truncated, dimeric form harboring the N‐terminal end containing the substrate and the cofactor binding domains. A model ensemble of the tetrameric hPHGDH was generated using AlphaFold coupled with molecular dynamics refinement. By analyzing the inter‐subunit interactions at the tetrameric interface, the residues F418, L478, P479, R454, and Y495 were selected and their role was studied by the alanine‐scanning mutagenesis approach. The F418A variant modifies the putative ASB, slightly alters the activity, the fraction of protein in the tetrameric state, and the protein stability; it seems relevant in dimers' recognition to yield the tetrameric oligomer. On the contrary, the R454A, L478A, P479A, and Y495A variants (ACT domain) determine a loss of the tetrameric assembly, resulting in low stability and misfolding, triggering the aggregation and hampering the activity. The predicted tetrameric interface seems mediated by residues at the ACT domain, and the tetramer formation seems crucial for proper folding of hPHGDH, which, in turn, is essential for both stability and functionality.

Stoichiometry and architecture of the human pyruvate dehydrogenase complex

Architecture of Intact Mammalian Pyruvate Dehydrogenase Complex Revealed Byin-Situstructural Analysis

Architecture of intact mammalian pyruvate dehydrogenase complex revealed by structural analysis

Architecture of intact mammalian pyruvate dehydrogenase complex revealed by in-situ structural analysis

Dimerization of a 5-kDa domain defines the architecture of the 5-MDa gammaproteobacterial pyruvate dehydrogenase complex

THEORETICAL STUDY TOWARD UNDERSTANDING THE CATALYTIC MECHANISM OF PYRUVATE DEHYDROGENASE MULTIENZYME COMPLEX E1 COMPONENT

Crystal structure of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase

On the quaternary structure of human D‐3‐phosphoglycerate dehydrogenase

Elucidation of the Interaction Loci of the Human Pyruvate Dehydrogenase Complex E2·E3BP Core with Pyruvate Dehydrogenase Kinase 1 and Kinase 2 by H/D Exchange Mass Spectrometry and Nuclear Magnetic Resonance

Molecular architecture of the mammalian 2-oxoglutarate dehydrogenase complex

Intricate Crystal Structure of Dihydrolipoamide Dehydrogenase (E3) with Its Binding Protein: Multiple Copies, Dynamic and Static Disorders

Architecture of Human Mitochondrial Respiratory Megacomplex I2III2IV2

Structure of the turnover-ready state of an ancestral respiratory complex I

The plasticity of the pyruvate dehydrogenase complex confers a labile structure that is associated with its catalytic activity

Fundamental Studies on Activity of Pyruvate Dehydrogenase

Structure, dimeric conformation, and coenzyme versatility of p-hydroxybenzoate hydroxylase from Arthrobacter sp. PAMC25564

The pyruvate dehydrogenase complex at the epigenetic crossroads of acetylation and lactylation

Structure and allosteric regulation of human NAD-dependent isocitrate dehydrogenase

Structural basis for the activity and regulation of human α-ketoglutarate dehydrogenase revealed by Cryo-EM

Crystal Structures of Human Glycerol 3-Phosphate Dehydrogenase 1 (GPD1).

Structure of the human respiratory complex II